Biblioteca Virtuale per la Salute – Piemonte – "Le biblioteche non si fanno…crescono" A. Birrell

Sfoglia per AUTORE
MOIA R
Collezione AO Cuneo

Items : 11

Role of chemotherapy in the treatment of chronic lymphocytic leukemia in the era of targeted therapies in Italy. A Campus CLL network report. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):201-204. doi: 10.1002/hon.3047. Epub 2022 Aug 19.

2023
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU Novara

Marasca R; Foà R; Ballotta L; Moia R; Cuneo A; Chiurazzi F; Reda G; Gottardi D; Orsucci L; Maccaferri M; De Paoli L;

Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study. in Hematological oncology / Hematol Oncol. 2023 Dec;41(5):877-883. doi: 10.1002/hon.3199. Epub 2023 Jul 1.

2023
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AOU Alessandria

Laurenti L; Cuneo A; Foà R; Trentin L; Coscia M; Rigolin GM; Mattiello V; Gattei V; Sportoletti P; Scortechini I; Moia R; Gentile M; Catania G; Loseto G; Chiurazzi F; Malerba L; De Paolis MR; Angeletti I; Ferrari A; Giordano A; Baratè C; Quaresmini G; Leone MMA; Farina L; Fresa A; Piciocchi A; Vitale C; Reda G; Visentin A; et alii...

Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model. in American journal of hematology / Am J Hematol. 2022 May;97(5):E176-E180. doi: 10.1002/ajh.26502. Epub 2022 Feb 25.

2022
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AOU Novara

Mauro FR; Trentin L; Foa' R; Tedeschi A; Gaidano G; Cuneo A; Coscia M; Guarente V; Noto A; Ielo C; Deodato M; Del Poeta G; Stelitano C; Moia R; Giordano A; Levato L; Rigolin GM; Gentile M; Murru R; De Paoli L; Laurenti L; Vitale C; Ciolli S; Chiarenza A; Sportoletti P; Frustaci AM; Visentin A; Reda G; Giannarelli D; et alii...

Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial. in British journal of haematology / Br J Haematol. 2022 Mar;196(5):1184-1193. doi: 10.1111/bjh.17971. Epub 2021 Dec 23.

2022
AOU Alessandria
ASL Cuneo 1
AOU Città della Salute di Torino
AO Cuneo
AOU Novara

Pileri SA; Tucci A; Balzarotti M; Gaidano G; Ladetto M; Motta G; Santambrogio E; Righi S; Moia R; Martelli M; Melle F; Di Rocco A; Ciccone G; Evangelista A; Nassi L; Agostinelli C; Novo M; Chiappella A; Diop F; Vitolo U;

Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study. in Haematologica / Haematologica. 2022 Jun 1;107(6):1470-1473. doi: 10.3324/haematol.2021.280325.

2022
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AOU Novara

Cuneo A; Laurenti L; Ghia P; Foà R; Trentin L; Pompili M; Tedeschi A; Mauro FR; Del Poeta G; Scarfò L; Autore F; Tomasso A; Di Sevo D; Arena V; Deodato M; Ielo C; Frustaci AM; Piciocchi A; Rughini A; Cassin R; Albano F; Quaglia FM; Pennese E; Moia R; Gentile M; Murru R; Motta M; Coscia M; Visentin A; et alii...

Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. in American journal of hematology / Am J Hematol. 2021 May 1;96(5):E168-E171. doi: 10.1002/ajh.26127. Epub 2021 Feb 24.